DaVita Shares Slip 1.32% Despite Positive Trading Session for S&P 500

🌧️Trending News

DAVITA ($NYSE:DVA): DaVita Inc., a leading provider of healthcare services, saw its shares slip 1.32% to $104.76 on Wednesday, despite the S&P 500 index’s overall positive performance. The company also provides managed care services to members in its contracted network, including clinical research, disease and case management, chronic kidney disease (CKD) education and wellness programs, anemia management, nutrition counseling, transportation services, and home therapies. Additionally, DaVita operates medical groups in Colorado and California, and has a medical group joint venture in Texas. Investors are likely cautious of the ongoing geopolitical tensions in the Middle East and the potential impact on the global economy.

Analysis

At GoodWhale, we recently conducted a comprehensive review of DAVITA INC‘s wellbeing. Our analysis revealed that DAVITA INC is a low risk investment with a Risk Rating of ‘3’. This indicates that the company is in a position of financial and business health and stability. Despite the low risk score, our analysis picked up on two potential risks in their balance sheet and cashflow statement. We encourage all investors to register with us to gain full access to our detailed report in order to explore these risks further. Our reports provide investors with an in-depth understanding of the company’s wellbeing, allowing them to make the most informed decisions possible. More…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Davita Inc. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Davita Inc. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Davita Inc. More…

Key Ratios Snapshot

Some of the financial key ratios for Davita Inc are shown below. More…

Peers

In the dialysis industry, DaVita Inc. competes with Acadia Healthcare Co Inc, Fresenius Medical Care AG & Co. KGaA, Medical Facilities Corp, and other companies. The company has a network of 2,664 outpatient dialysis centers in the United States that serve approximately 198,000 patients with end-stage renal disease.

– Acadia Healthcare Co Inc ($NASDAQ:ACHC)

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services. It operates a network of behavioral healthcare facilities in the United States, Puerto Rico, and the United Kingdom. The company offers inpatient psychiatric and substance abuse services, residential treatment, outpatient behavioral health services, and specialty behavioral healthcare services.

– Fresenius Medical Care AG & Co. KGaA ($LTS:0H9X)

Fresenius Medical Care AG & Co. KGaA, a renal care company, provides products and services for patients with renal diseases worldwide. The company’s products and services include dialysis machines, dialyzers, and related disposable products, as well as renal pharmaceuticals. It also offers clinical laboratory testing services. The company was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

– Medical Facilities Corp ($TSX:DR)

Medical Facilities Corporation is a leading operator of specialty surgical hospitals and ancillary services in the United States. The company owns and operates seven specialty surgical hospitals, one surgical hospital, and three surgical facilities located in Arkansas, Illinois, Louisiana, Mississippi, Oklahoma, and Texas. Medical Facilities Corporation’s hospitals offer a broad range of services, including general surgery, cardiovascular surgery, orthopedic surgery, pain management, gastroenterology, urology, and otolaryngology. The company’s hospitals are accredited by the Joint Commission on Accreditation of Healthcare Organizations and are licensed by the respective state Departments of Health.

Summary

Investing in Davita Inc. (NYSE: DVA) has proved to be a wise decision today, as the stock market saw an overall increase in the S&P 500. Despite this, shares of Davita Inc. dropped 1.32% to $104.76. It is important for investors to do their research when considering this stock.

The company has shown solid growth over the last few years due to its focus on high quality care and services. It has a strong presence in the healthcare industry and is well-positioned for further growth. Investors should weigh the potential risks and rewards before making any investments in this company.